Emergen Research has taken another significant step in strengthening its position as a trusted provider of market intelligence by introducing its latest Continuous Glucose Monitoring market research content. This comprehensive offering is designed to help businesses better understand complex market dynamics while equipping them with the tools needed to make confident and strategic decisions.
The Continuous Glucose Monitoring market is expected to grow from an estimated USD 5.1 billion in 2025 to USD 14.4 billion in 2035, at a CAGR of 12.20%.
The rise in diabetes prevalence due to ageing, obesity, and an unhealthy lifestyle is one of the factors driving the continuous glucose monitoring (CGM) device market. Obesity is a key contributor to diabetes.
According to the World Health Organization, the global obesity rate will approach 1 billion in 2022, comprising 650 million adults, 340 million adolescents, and 39 million children. This figure continues to rise. If current trends continue, the World Health Organization projects that by 2025, around 167 million individuals, both adults and children, will have worsening health problems as a result of their weight difficulties. In addition to obesity, diabetes is becoming more common worldwide.
According to the International Diabetes Federation (IDF), 537 million adults (aged 20-79) had diabetes in 2021, with that figure predicted to rise to 642 million by 2040. According to the IDF, diabetes is becoming more common all over the world, with low- and middle-income countries experiencing the greatest growth.
The rising incidence of prediabetes is also driving market expansion. Prediabetes is a condition in which blood sugar levels are higher than usual but not high enough to be diagnosed with type 2 diabetes. It is a dangerous medical disorder that raises the chance of acquiring type 2 diabetes, heart disease, and stroke. Unfortunately, the number of persons diagnosed with prediabetes is increasing fast.
The primary cause of the increase in prediabetes instances is the rise in obesity prevalence. Obesity is a significant risk factor for prediabetes and type 2 diabetes. As more people embrace sedentary lifestyles and eat poor diets, the prevalence of obesity rises, increasing prediabetes. According to the CDC and the US Department of Health and Human Services, it is anticipated that 97.6 million adults in the United States aged 18 and up will have prediabetes in 2021.
At the heart of this research lies a strong focus on delivering value to a diverse audience. The report is particularly useful for key market players, investors, venture capitalists, and organizations of all sizes, ranging from startups to large enterprises. Additionally, research institutions, consulting firms, and government bodies can leverage the insights provided to support planning, policy-making, and strategic initiatives.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4417
-
Component Outlook (Revenue, USD Billion; 2020-2035)
- Transmitters
- Sensors
- Receivers
-
Connectivity Outlook (Revenue, USD Billion; 2020-2035)
- Bluetooth
- 4G
-
Vertical Outlook (Revenue, USD Billion; 2020-2035)
- Hospitals
- Homecare Settings
- Others
-
Regional Outlook (Revenue, USD Billion; 2020-2035)
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
One of the most important aspects of this research content is its ability to transform raw data into actionable insights. Businesses today do not just need information—they need clarity and direction. Emergen Research addresses this need by presenting data in a structured and easy-to-understand format, ensuring that users can quickly interpret findings and apply them to real-world scenarios.
The Continuous Glucose Monitoring market research content has been developed using advanced research methodologies and a combination of primary and secondary data sources. This ensures a high level of accuracy and reliability. The content includes detailed reports, whitepapers, case studies, and trend analyses that cover a wide range of industries such as healthcare, technology, finance, manufacturing, and consumer goods. This broad industry coverage makes the research highly versatile and relevant for various business applications.
Competitive landscape:-
A major highlight of the report is its in-depth competitive landscape analysis. Understanding the competition is essential for any business aiming to succeed in today’s crowded market. The report provides detailed profiles of leading companies in the global Continuous Glucose Monitoring market and examines their strategies, strengths, and recent developments. It also covers key activities such as mergers and acquisitions, partnerships, collaborations, product launches, and technological advancements. This information allows businesses to benchmark their performance and identify opportunities to gain a competitive advantage.
Rise in burden of diabetes to propel market growth
The rising prevalence of diabetes is a primary growth factor in the continuous glucose monitoring (CGM) market. As diabetes spreads around the world, more people seek effective ways to keep blood glucose levels stable. CGM systems empower users with the opportunity to make informed decisions about their food, exercise, and medicine, ultimately improving health outcomes.
The expanding knowledge of diabetes management, combined with healthcare professionals' increased emphasis on glucose monitoring as a normal practice, fuels demand for CGM devices. Technological advancements have also simplified and made these systems more accessible to patients, encouraging their adoption. This growing emphasis on proactive diabetes care is projected to propel the CGM industry in the coming years.
For instance, the International Diabetes Federation (IDF) reports that over 537 billion individuals (aged 20 to 79 years) worldwide have diabetes, which is projected to increase to over 643 billion by 2030 and over 783 billion by 2045. This, in turn, is projected to drive up global usage of continuous glucose monitoring devices.
Market segmentation:-
Equally important is the report’s detailed market segmentation. The Continuous Glucose Monitoring market is divided into multiple segments based on product types, applications, end-user industries, and geographical regions. This segmentation helps businesses gain a deeper understanding of demand patterns, production levels, and consumption trends across different areas. By identifying high-growth segments, organizations can focus their efforts more effectively and maximize their returns.
The CGM industry represents a rapidly progressing sector focusing on providing real-time data on blood glucose levels in individuals who have diabetes. The user can use the CGM system for continuous tracking of glucose levels, thus ensuring better control over the disorder and, subsequently, better health outcomes.
Leading companies in the industry include Dexcom, Abbott Laboratories, and Medtronic, which specialise in novel technology and highly user-friendly devices. The increasing incidence of diabetes, coupled with the awareness of the need for glucose control, is driving the demand for CGM systems. Furthermore, the integration of smartphones and data analytics is further enhancing the appeal of CGM solutions in the healthcare market.
In January 2025, Medtronic plc announced that its MiniMed 780G system with Simplera Sync had obtained CE Mark clearance. Simple Sync is a technique that improves the user experience by simplifying the two-step insertion process. In addition, this new sensor is half the size of its predecessors.
The MiniMed 780G system with Simplera Sync sensor is expected to launch in Europe via a limited release in the spring of 2025, followed by a phased commercial introduction in the summer of the same year.
Some of the key companies in the global Continuous Glucose Monitoring Market include:
- Dexcom, Inc.
- Abbott
- Medtronic
- Ypsomed AG
- Senseonics Holdings, Inc.
- A. Menarini Diagnostics S.r.l.
- Signos, Inc.
Another key strength of the research lies in its actionable recommendations. The report goes beyond analysis by providing practical suggestions that businesses can implement to improve their strategies. Whether it is enhancing product offerings, optimizing operations, or exploring new markets, these recommendations are tailored to address specific industry challenges and opportunities.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4417
In addition to its analytical depth, the report also emphasizes the importance of staying updated with current market trends. Markets are influenced by various factors, including technological advancements, economic changes, and evolving consumer behavior. Emergen Research ensures that its content is regularly updated to reflect the latest developments, allowing businesses to remain agile and responsive in a rapidly changing environment.
Another notable feature is the inclusion of expert insights. The analysts behind the report bring extensive industry experience and a deep understanding of market dynamics. Their ability to interpret complex data and identify meaningful trends adds significant value to the research. These insights help businesses not only understand current conditions but also anticipate future developments.
Furthermore, the report is designed with usability in mind. The content is structured in a way that makes it accessible to both experienced professionals and those new to market research. Clear explanations, organized sections, and logical flow ensure that users can easily navigate the report and extract relevant information.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/continuous-glucose-monitoring-market
Emergen Research continues to focus on empowering businesses with knowledge that drives growth and innovation. By combining detailed analysis, expert insights, and practical recommendations, the company ensures that its clients are well-equipped to navigate complex market environments and achieve their objectives.
About Emergen Research
Emergen Research is a leading market research and consulting firm that provides syndicated reports, customized research solutions, and strategic consulting services. The company specializes in analyzing consumer behavior, identifying market trends, and delivering actionable insights across multiple industries. With a strong commitment to accuracy and relevance, Emergen Research helps businesses make smarter decisions and achieve sustainable growth.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com